Trial intelligence / Profile preview

Pamiparib maintenance vs placebo in advanced gastric cancer after platinum chemotherapy

CTR20171664Phase 2Completed

Sponsor
BeiGene
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pamiparib in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by BeiGene. Started Apr 2018; status: completed.

02

Drugs

pamiparib
03

Conditions

gastric adenocarcinomagastroesophageal junction adenocarcinoma

Beyond the preview

Go deeper on CTR20171664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20171664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call